The Company’s flagship technology to be featured during a two-day educational conference that draws the world’s top cardiac electrophysiology experts
Westport, CT, May 25, 2022 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (NASDAQ:BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering greater intracardiac signal fidelity through its proprietary signal processing platform, today announced that its flagship technology will be featured during EPlive, a hybrid event taking place at St. David’s Medical Center in Austin, Texas from June 2-3, 2022.
EPLive is a two-day intensive educational meeting for practicing clinical cardiac electrophysiologists, electrophysiologist fellows and general cardiologists who have an interest in treating complex cardiac arrhythmias. During the event, BioSig will be exhibiting and offering technology demonstrations, including features of its newly released PURE EP NOVA-5 Software. Enhanced with NOVA-5 Software, the Company believes that the PURE EP(TM) System delivers a new standard in signal processing, offering greater customization and smarter workflows. Additionally, the Company will showcase the next generation of PURE EP(TM) Software Modules currently in advanced development stages.
The concept for EPLive was first created and developed by Dr. Andrea Natale, Cardiac Electrophysiologist at St. David’s Medical Center in Austin, Texas. As an internationally respected physician and leader in the field of cardiac electrophysiology, Dr. Natale is passionate about education, training and knowledge sharing when it comes to delivering the best possible care to arrhythmia patients. As the first center to commercially adopt the PURE EP(TM) System, Dr. Natale and the physicians at Texas Cardiac Arrhythmia Institute (TCAI) have performed over 500 cases with the PURE EP(TM) System since its installation in November 2019.
“We have spent approximately thirteen years working in collaboration with the physicians at TCAI to bring this important innovation to market. Our collaboration with this center of excellence has supported our company in so many positive ways and we are excited to participate in this great event,” commented Kenneth L. Londoner, Chairman and CEO of BioSig Technologies, Inc.
To register to attend the event, please click here.
